These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8663536)

  • 1. The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression.
    David M; Zhou G; Pine R; Dixon JE; Larner AC
    J Biol Chem; 1996 Jul; 271(27):15862-5. PubMed ID: 8663536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.
    David M; Chen HE; Goelz S; Larner AC; Neel BG
    Mol Cell Biol; 1995 Dec; 15(12):7050-8. PubMed ID: 8524272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
    You M; Yu DH; Feng GS
    Mol Cell Biol; 1999 Mar; 19(3):2416-24. PubMed ID: 10022928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation.
    Ali S; Chen Z; Lebrun JJ; Vogel W; Kharitonenkov A; Kelly PA; Ullrich A
    EMBO J; 1996 Jan; 15(1):135-42. PubMed ID: 8598196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways.
    Min W; Pober JS; Johnson DR
    Circ Res; 1998 Oct; 83(8):815-23. PubMed ID: 9776728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
    Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
    J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells.
    Berger LC; Hawley RG
    Blood; 1997 Jan; 89(1):261-71. PubMed ID: 8978300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
    Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
    J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
    Li C; Friedman JM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors.
    Rivard N; McKenzie FR; Brondello JM; Pouysségur J
    J Biol Chem; 1995 May; 270(18):11017-24. PubMed ID: 7537742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
    Kim HY; Park EJ; Joe EH; Jou I
    J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor induces coupling of protein-tyrosine phosphatase 1D to GRB2 via the COOH-terminal SH3 domain of GRB2.
    Wong L; Johnson GR
    J Biol Chem; 1996 Aug; 271(35):20981-4. PubMed ID: 8702859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells.
    You M; Zhao Z
    J Biol Chem; 1997 Sep; 272(37):23376-81. PubMed ID: 9287352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.
    Bennett AM; Tang TL; Sugimoto S; Walsh CT; Neel BG
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7335-9. PubMed ID: 8041791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.